Genetic validation of aldolase and glyceraldehyde-3-phosphate dehydrogenase as drug targets in Trypanosoma brucei.

Aldolase (ALD) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of Trypanosoma brucei are considered to be promising targets for chemotherapeutic treatment of African sleeping sickness, because glycolysis is the single source of ATP for the parasite when living in the human bloodstream. Moreover, these enzymes appeared to possess distinct kinetic and structural properties that have already been exploited for the discovery of effective and selective inhibitors with trypanocidal activity. Here we present an experimental, quantitative assessment of the importance of these enzymes for the glycolytic pathway. This was achieved by decreasing the concentrations of ALD and GAPDH by RNA interference. The effects of these knockdowns on parasite growth, levels of various enzymes and transcripts, enzyme activities and glucose consumption were studied. A partial depletion of ALD and GAPDH was already sufficient to rapidly kill the trypanosomes. An effect was also observed on the activity of some other glycolytic enzymes.

[1]  C. Clayton,et al.  Vectors for inducible expression of toxic gene products in bloodstream and procyclic Trypanosoma brucei. , 1997, Molecular and biochemical parasitology.

[2]  J. Chambers,et al.  The anti-trypanosomal agent lonidamine inhibits Trypanosoma brucei hexokinase 1. , 2008, Molecular and biochemical parasitology.

[3]  Zefeng Wang,et al.  The Adenosine Analog Tubercidin Inhibits Glycolysis in Trypanosoma brucei as Revealed by an RNA Interference Library* , 2003, Journal of Biological Chemistry.

[4]  Glaucius Oliva,et al.  Structural Basis for Selective Inhibition of Trypanosomatid Glyceraldehyde-3-Phosphate Dehydrogenase: Molecular Docking and 3D QSAR Studies , 2008, J. Chem. Inf. Model..

[5]  J. F. Ryley,et al.  Studies on the metabolism of the Protozoa. 7. Comparative carbohydrate metabolism of eleven species of trypanosome. , 1956, The Biochemical journal.

[6]  Andreas Seyfang,et al.  Specificity of glucose transport in Trypanosoma brucei , 1991 .

[7]  Barbara M. Bakker,et al.  Glycolysis in Bloodstream Form Trypanosoma brucei Can Be Understood in Terms of the Kinetics of the Glycolytic Enzymes* , 1997, The Journal of Biological Chemistry.

[8]  M. Walkinshaw,et al.  Design, synthesis and trypanocidal activity of lead compounds based on inhibitors of parasite glycolysis. , 2008, Bioorganic & medicinal chemistry.

[9]  C L Verlinde,et al.  Glycolysis as a target for the design of new anti-trypanosome drugs. , 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[10]  L. Azéma,et al.  Cell permeation of a Trypanosoma brucei aldolase inhibitor: evaluation of different enzyme-labile phosphate protecting groups. , 2006, Bioorganic & medicinal chemistry letters.

[11]  F. Opperdoes,et al.  Glycolytic enzymes of Trypanosoma brucei. Simultaneous purification, intraglycosomal concentrations and physical properties. , 1986, European journal of biochemistry.

[12]  N. Chabot,et al.  Selective irreversible inhibition of fructose 1,6-bisphosphate aldolase from Trypanosoma brucei. , 2006, Journal of medicinal chemistry.

[13]  F. Opperdoes,et al.  Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Barbara M. Bakker,et al.  Roles of triosephosphate isomerase and aerobic metabolism in Trypanosoma brucei. , 2001, The Biochemical journal.

[15]  F. Opperdoes,et al.  The inhibition of pyruvate transport across the plasma membrane of the bloodstream form of Trypanosoma brucei and its metabolic implications. , 1995, The Biochemical journal.

[16]  Solomon Nwaka,et al.  Innovative lead discovery strategies for tropical diseases , 2006, Nature Reviews Drug Discovery.

[17]  M. Gelb,et al.  A disubstituted NAD+ analogue is a nanomolar inhibitor of trypanosomal glyceraldehyde-3-phosphate dehydrogenase. , 2001, Bioorganic & medicinal chemistry letters.

[18]  F. Opperdoes,et al.  Localization of nine glycolytic enzymes in a microbody‐like organelle in Trypanosoma brucei: The glycosome , 1977, FEBS letters.

[19]  F. Opperdoes,et al.  Enzymes of carbohydrate metabolism as potential drug targets. , 2001, International journal for parasitology.

[20]  F. Opperdoes,et al.  Simultaneous purification of hexokinase, class-I fructose-bisphosphate aldolase, triosephosphate isomerase and phosphoglycerate kinase from Trypanosoma brucei. , 1984, European journal of biochemistry.

[21]  Barbara M. Bakker,et al.  Experimental and in Silico Analyses of Glycolytic Flux Control in Bloodstream Form Trypanosoma brucei* , 2005, Journal of Biological Chemistry.